Thrivent Financial for Lutherans’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
84,309
+1,957
| +2% | +$42.5K | ﹤0.01% | 1412 |
|
|
2025
Q1 | $2M | Sell |
82,352
-4,308
| -5% | -$104K | ﹤0.01% | 1291 |
|
|
2024
Q4 | $1.81M | Sell |
86,660
-952
| -1% | -$19.9K | ﹤0.01% | 1506 |
|
|
2024
Q3 | $1.74M | Sell |
87,612
-5,538
| -6% | -$110K | ﹤0.01% | 1539 |
|
|
2024
Q2 | $1.44M | Sell |
93,150
-3,740
| -4% | -$57.9K | ﹤0.01% | 1615 |
|
|
2024
Q1 | $1.54M | Buy |
96,890
+7,591
| +9% | +$121K | ﹤0.01% | 1607 |
|
|
2023
Q4 | $1.5M | Sell |
89,299
-2,353
| -3% | -$39.6K | ﹤0.01% | 1581 |
|
|
2023
Q3 | $1.07M | Sell |
91,652
-1,618
| -2% | -$18.9K | ﹤0.01% | 1694 |
|
|
2023
Q2 | $1.25M | Sell |
93,270
-1,615
| -2% | -$21.7K | ﹤0.01% | 1656 |
|
|
2023
Q1 | $1.57M | Sell |
94,885
-3,326
| -3% | -$55.1K | ﹤0.01% | 1466 |
|
|
2022
Q4 | $1.83M | Buy |
98,211
+427
| +0.4% | +$7.94K | ﹤0.01% | 1312 |
|
|
2022
Q3 | $1.26M | Buy |
+97,784
| New | +$1.26M | ﹤0.01% | 1523 |
|